Lung cancer bronchogenic carcinoma

Bronchogenic carcinoma A lung cancer associated with asbestos exposure. 

Primary bronchogenic carcinoma complicates UIP in 5% to 13% of patients (153-157). The increased risk of lung cancer in IPF may occur in nonsmokers (154), but smoking increases the risk (153,155). Surgical resection is the treatment of choice for patients with localized non-small cell lung cancer (NSCLC) but morbidity and mortality rates are higher in patients with underlying IPF (156,157). 

Bronchogenic carcinoma develops in the native lung of transplant recipients with emphysema and pulmonary fibrosis at frequencies of 2% and 4%, respectively. The carcinomas most commonly manifest as a pulmonary nodule or mass on chest radiographs, with more nodules seen on CT scans (Collins et al. 2002). This rate is similar to that in other high-risk populations (e.g. elderly smokers with emphysema or other chronic lung disease). The majority of cancers are associated with a poor prognosis. The most common imaging manifestations are a solitary pulmonary nodule or mass. 

---